Advertisement

Are antiseptic-coated central venous catheters effective in a real-world setting?

Published:December 05, 2005DOI:https://doi.org/10.1016/j.ajic.2005.08.004

      Background

      Catheter-related bloodstream infections are common, costly, and morbid. Randomized controlled trials indicate that antiseptic-coated central venous catheters reduce infection rates.

      Objective

      To assess the clinical and economic effectiveness of antiseptic-coated catheters for critically ill patients in a real-world setting.

      Methods

      Central venous catheters coated with chlorhexidine/silver-sulfadiazene were introduced in all patients requiring central venous access in adult intensive care units at the University of Michigan Health System, a large, tertiary care teaching hospital. A pretest-posttest cohort design measured the primary outcome of catheter-related bloodstream infection rate, comparing the 2 years prior to the intervention with the 2 years following the intervention. We also evaluated cost-effectiveness and changes in vancomycin use.

      Results

      The intervention was associated with a 4% per month relative reduction in the incidence of catheter-related bloodstream infection, after controlling for the effects of time. Overall, a 35% relative risk reduction (P < .0003) in the catheter-related bloodstream infection rate occurred in the posttest phase. The use of antiseptic-coated catheters reduced costs more than $100,000 annually. Vancomycin use was less in units in which antiseptic catheters were used compared with wards in which these catheters were not used.

      Conclusion

      Antiseptic-coated catheters appear to be clinically effective and economically efficient in a real-world setting.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. National Nosocomial Infections Surveillance (NNIS) System report, Data summary from January 1990-May 1999, issued June 1999.
        Am J Infect Control. 1999; 27: 520-532
        • Mermel L.A.
        Prevention of intravascular catheter-related infections.
        Ann Intern Med. 2000; 132: 391-402
        • Pittet D.
        • Tarara D.
        • Wenzel R.P.
        Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality.
        JAMA. 1994; 271: 1598-1601
        • Collignon P.J.
        Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis.
        Med J Aust. 1994; 161: 374-378
        • Safdar N.
        • Kluger D.M.
        • Maki D.G.
        A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies.
        Medicine (Baltimore). 2002; 81: 466-479
        • Saint S.
        • Veenstra D.L.
        • Lipsky B.A.
        The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?.
        Infect Control Hosp Epidemiol. 2000; 21: 375-380
        • Rello J.
        • Ochagavia A.
        • Sabanes E.
        • Roque M.
        • Mariscal D.
        • Reynaga E.
        • et al.
        Evaluation of outcome of intravenous catheter-related infections in critically ill patients.
        Am J Respir Crit Care Med. 2000; 162: 1027-1030
        • Dimick J.B.
        • Pelz R.K.
        • Consunji R.
        • Swoboda S.M.
        • Hendrix C.W.
        • Lipsett P.A.
        Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit.
        Arch Surg. 2001; 136: 229-234
        • Veenstra D.L.
        • Saint S.
        • Sullivan S.D.
        Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection.
        JAMA. 1999; 282: 554-560
        • Eyer S.
        • Brummitt C.
        • Crossley K.
        • Siegel R.
        • Cerra F.
        Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance.
        Crit Care Med. 1990; 18: 1073-1079
        • Cobb D.K.
        • High K.P.
        • Sawyer R.G.
        • Sable C.A.
        • Adams R.B.
        • Lindley D.A.
        • et al.
        A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters.
        N Engl J Med. 1992; 327: 1062-1068
        • Nystrom B.
        Impact of handwashing on mortality in intensive care: examination of the evidence.
        Infect Control Hosp Epidemiol. 1994; 15: 435-436
        • Doebbeling B.N.
        • Stanley G.L.
        • Sheetz C.T.
        • Pfaller M.A.
        • Houston A.K.
        • Annis L.
        • et al.
        Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units.
        N Engl J Med. 1992; 327: 88-93
        • Maki D.G.
        • Ringer M.
        • Alvarado C.J.
        Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters.
        Lancet. 1991; 338: 339-343
        • Mimoz O.
        • Pieroni L.
        • Lawrence C.
        • Edouard A.
        • Costa Y.
        • Samii K.
        • et al.
        Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
        Crit Care Med. 1996; 24: 1818-1823
        • Veenstra D.L.
        • Saint S.
        • Saha S.
        • Lumley T.
        • Sullivan S.D.
        Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
        JAMA. 1999; 281: 261-267
        • Bach A.
        Clinical studies on the use of antibiotic- and antiseptic-bonded catheters to prevent catheter-related infection.
        Zentralbl Bakteriol. 1995; 283: 208-214
        • Tennenberg S.
        • Lieser M.
        • McCurdy B.
        • Boomer G.
        • Howington E.
        • Newman C.
        • et al.
        A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections.
        Arch Surg. 1997; 132: 1348-1351
        • Maki D.G.
        • Stolz S.M.
        • Wheeler S.
        • Mermel L.A.
        Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial.
        Ann Intern Med. 1997; 127: 257-266
        • Logghe C.
        • Van Ossel C.
        • D'Hoore W.
        • Ezzedine H.
        • Wauters G.
        • Haxhe J.J.
        Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial.
        J Hosp Infect. 1997; 37: 145-156
        • Garner J.S.
        • Jarvis W.R.
        • Emori T.G.
        • Horan T.C.
        • Hughes J.M.
        CDC definitions for nosocomial infections, 1988.
        Am J Infect Control. 1988; 16: 128-140
      2. Preventing the Spread of Vancomycin Resistance–A Report from the Hospital Infection Control Practices Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial-Resistant Microorganisms in Hospitals; comment period and public meeting–CDC. Notice.
        Federal Register. 1994; 59: 25758-25763
        • Pauker S.G.
        Deciding about screening.
        Ann Intern Med. 1993; 118: 901-902
        • Digiovine B.
        • Chenoweth C.
        • Watts C.
        • Higgins M.
        The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.
        Am J Respir Crit Care Med. 1999; 160: 976-981
        • O'Grady N.P.
        • Alexander M.
        • Dellinger E.P.
        • Gerberding J.L.
        • Heard S.O.
        • Maki D.G.
        • et al.
        Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.
        MMWR Recomm Rep. 2002; 51: 1-29
        • Stosor V.
        • Peterson L.R.
        • Postelnick M.
        • Noskin G.A.
        Enterococcus faecium bacteremia: does vancomycin resistance make a difference?.
        Arch Intern Med. 1998; 158: 522-527
        • Carmeli Y.
        • Samore M.H.
        • Huskins C.
        The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.
        Arch Intern Med. 1999; 159: 2461-2468
        • Cetinkaya Y.
        • Falk P.S.
        • Mayhall C.G.
        Effect of gastrointestinal bleeding and oral medications on acquisition of vancomycin-resistant Enterococcus faecium in hospitalized patients.
        Clin Infect Dis. 2002; 35: 935-942
        • Fridkin S.K.
        • Edwards J.R.
        • Courval J.M.
        • Hill H.
        • Tenover F.C.
        • Lawton R.
        • et al.
        The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units.
        Ann Intern Med. 2001; 135: 175-183
        • D'Agata E.M.
        • Green W.K.
        • Schulman G.
        • Li H.
        • Tang Y.W.
        • Schaffner W.
        Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition.
        Clin Infect Dis. 2001; 32: 23-29
      3. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
        MMWR Recomm Rep. 1995; 44: 1-13
        • Fridkin S.K.
        • Edwards J.R.
        • Pichette S.C.
        • Pryor E.R.
        • McGowan Jr., J.E.
        • Tenover F.C.
        • et al.
        Determinants of vancomycin use in adult intensive care units in 41 United States hospitals.
        Clin Infect Dis. 1999; 28: 1119-1125
        • Raad I.
        • Darouiche R.
        • Dupuis J.
        • Abi-Said D.
        • Gabrielli A.
        • Hachem R.
        • et al.
        Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. The Texas Medical Center Catheter Study Group.
        Ann Intern Med. 1997; 127: 267-274
        • Raad I.
        • Darouiche R.
        • Hachem R.
        • Mansouri M.
        • Bodey G.P.
        The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin.
        J Infect Dis. 1996; 173: 418-424
        • Chaiyakunapruk N.
        • Veenstra D.L.
        • Lipsky B.A.
        • Saint S.
        Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis.
        Ann Intern Med. 2002; 136: 792-801
        • Chaiyakunapruk N.
        • Veenstra D.L.
        • Lipsky B.A.
        • Saint S.
        Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine.
        Clin Infect Dis. 2003; 37: 764-771